Interventions in the <font color="blue">initial_2</font> <font color="blue">prodromal_2</font> <font color="blue">states_2</font> <font color="blue">of_2</font> <font color="blue">psychosis_2</font> <font color="blue">in_1</font> <font color="blue">Germany_2</font> <font color="blue">:_2</font> concept and recruitment . 
<br>
<br> BACKGROUND The Early Detection and Intervention Programme of the German Research Network on <font color="blue">Schizophrenia_1</font> ( GRNS ) investigates the <font color="blue">initial_2</font> <font color="blue">prodromal_2</font> <font color="blue">phase_2</font> <font color="blue">of_2</font> <font color="blue">psychosis_2</font> in a multidimensional approach . Two intervention strategies are being studied by two large - scale multicentre projects . 
<br> AIMS To present the concept of the intervention studies , and to provide an interim report of the recruitment procedure . 
<br> METHOD Comprehensive cognitive - behavioural therapy has been developed for <font color="blue">patients_1</font> <font color="blue">in_1</font> <font color="blue">the_1</font> <font color="blue">"_1</font> <font color="blue">early_2</font> <font color="blue">initial_2</font> <font color="blue">prodromal_2</font> <font color="blue">state_2</font> <font color="blue">"_2</font> <font color="blue">._1</font> For <font color="blue">patients_1</font> <font color="blue">in_1</font> <font color="blue">the_1</font> <font color="blue">"_1</font> <font color="blue">late_2</font> <font color="blue">initial_2</font> <font color="blue">prodromal_2</font> <font color="blue">state_2</font> <font color="blue">"_2</font> the atypical neuroleptic amisulpride is explored . Both interventions are evaluated in randomised controlled trials using clinical management as the control condition . 
<br> <font color="blue">RESULTS_1</font> <font color="blue">Between_1</font> <font color="blue">January_1</font> <font color="blue">2001_1</font> <font color="blue">and_1</font> <font color="blue">March_1</font> <font color="blue">2003_1</font> <font color="blue">,_1</font> <font color="blue">1212_4</font> <font color="blue">individuals_6</font> <font color="blue">seeking_5</font> <font color="blue">help_5</font> <font color="blue">for_5</font> <font color="blue">mental_5</font> <font color="blue">health_5</font> <font color="blue">problems_5</font> <font color="blue">were_1</font> <font color="blue">screened_1</font> <font color="blue">for_1</font> <font color="blue">putative_1</font> <font color="blue">prodromal_1</font> symptoms at four university centres . <font color="blue">More_3</font> <font color="blue">than_3</font> <font color="blue">388_6</font> <font color="blue">individuals_6</font> <font color="blue">fulfilled_6</font> <font color="blue">criteria_6</font> <font color="blue">for_5</font> <font color="blue">both_5</font> <font color="blue">interventions_5</font> <font color="blue">and_5</font> <font color="blue">188_5</font> <font color="blue">(_5</font> <font color="blue">48.5%_5</font> <font color="blue">)_5</font> <font color="blue">gave_5</font> <font color="blue">informed_5</font> <font color="blue">consent_5</font> <font color="blue">to_5</font> <font color="blue">participate_5</font> <font color="blue">in_5</font> <font color="blue">the_5</font> <font color="blue">trials_5</font> <font color="blue">._5</font> <font color="blue">
<br>_2</font> CONCLUSIONS The screening procedure appears to be feasible and trial participation seems to be acceptable to a relevant proportion of people at increased risk of developing psychosis .